Remarkably, induction of heparanase before the appearance of malignancy was reported in essentially all of the above-mentioned inflammatory conditions, i.e., Barrett’s esophagus (68), hepatitis C infection (69), chronic pancreatitis (70), Crohn disease and ulcerative colitis (29, 50). This evidence concerns the gene HPSE and chronic pancreatitis.